A large pharmaceutical company needed to reorganize their US hospital sales force to better address the changing dynamics of hospital systems.  We gathered insights in three pilot markets to improve their sales approach to better reflect the interests of their organized clients.

A biotechnology company was looking to develop compounds for acute myloid leukemia, but had limited internal resources to evaluate the market.  We conducted a Market Opportunity Map to identify unmet needs and enhance their early stage decision making.

A large pharmaceutical company had a series of compounds with potential for treatment in prostate cancer.  They asked us to produce a Market Opportunity Map to highlight the various opportunities in this market and allow them to tailor their development programs and sequence their launches appropriately.

A mid-sized biotechnology company had a portfolio of products all focused on orphan diseases.  They wanted to provide access to all patients around the globe, and asked us to evaluate the market access processes not only in leading industrialized markets, but across all countries where there might be significant patient need.